Completed PHASE2 INTERVENTIONAL 1-arm NCT00870883

N-acetylcysteine Plus Deferoxamine for Patients With Hypotension

Prospective, Randomized, Double-blinded, Placebo-controlled Study of N-acetylcysteine Plus Deferoxamine for Patients With Hypotension as Prophylaxis for Acute Renal Failure

Sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico

Conditions Acute Renal Failure Hypotension

Interventions N-acetylcysteine and deferoxamine

Updated 6 times since 2017 Last updated: May 27, 2015 Started: Mar 31, 2009 Primary completion: May 31, 2015 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Acute Renal Failure and Hypotension, this trial is completed. The trial is conducted by Conselho Nacional de Desenvolvimento Científico e Tecnológico and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Conselho Nacional de Desenvolvimento Científico e Tecnológico
Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude

Data source: Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Criciúma, Brazil